Key Events This Week
29 Dec 2025: Stock opens at Rs.1,082, dips 0.25%
30 Dec 2025: New 52-week high at Rs.1,097 and all-time high at Rs.1,095
31 Dec 2025: Hits fresh 52-week high of Rs.1,107
2 Jan 2026: Week closes at Rs.1,107.70, down 0.22% on day
29 December 2025: Opening Dip Amid Market Weakness
Laurus Labs began the week at Rs.1,082.00, registering a slight decline of 0.25% on relatively moderate volume of 41,794 shares. This movement was in line with the broader market, as the Sensex fell 0.41% to close at 37,140.23. The stock’s minor pullback reflected cautious sentiment following the previous week’s gains, but it remained well supported above key technical levels.
30 December 2025: New 52-Week and All-Time Highs Signal Strong Momentum
On 30 December, Laurus Labs surged to a new 52-week high of Rs.1,097 and simultaneously touched an all-time high closing price of Rs.1,095. The stock gained 0.81% on the day, outperforming the Sensex which marginally declined by 0.01%. This marked a significant reversal after the opening day’s dip, driven by robust investor interest and positive sentiment around the company’s fundamentals.
The stock’s technical positioning was reinforced by trading above all major moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical strength was underpinned by Laurus Labs’ exceptional quarterly results, which reported a net profit growth of 993.4% in the September 2025 quarter, with profit before tax rising by 1233.17% to Rs.242.77 crores and profit after tax increasing by 882.7% to Rs.194.97 crores.
Institutional investors’ confidence was evident, with holdings at 37.63%, supporting the stock’s upward momentum. The company’s return on capital employed (ROCE) stood at a robust 16.75%, reflecting efficient capital utilisation. Despite a premium valuation, the stock traded at a discount relative to peers’ historical averages, providing some valuation comfort.
Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.
- - Investment Committee approved
- - 50+ candidates screened
- - Strong post-announcement performance
31 December 2025: Fresh 52-Week High Amid Broad Market Rally
Laurus Labs extended its gains on the last trading day of 2025, hitting a new 52-week high of Rs.1,107. The stock rose 1.60%, outperforming the Pharmaceuticals & Biotechnology sector by 0.92%. This marked the second consecutive day of gains, with a cumulative return of 2.26% over the two sessions.
The broader market was supportive, with the Sensex climbing 0.83% to 37,443.41. Small-cap stocks led the rally, and Laurus Labs’ strong technical position above all key moving averages further bolstered investor confidence.
Financially, the company’s quarterly results continued to impress, with operating profit to interest coverage ratio at 10.08 times and a sustained ROCE of 16.75%. Institutional ownership remained steady at 37.63%, reflecting ongoing confidence from sophisticated investors.
Get the full story on Laurus Labs Ltd! Our detailed research dives into fundamentals, sector comparison, technical analysis, and valuations for this mid-cap. Make informed decisions!
- - Full research story
- - Sector comparison done
- - Informed decision support
2 January 2026: Minor Pullback on Lower Volume
The week concluded with a slight decline of 0.22% to Rs.1,107.70 on relatively low volume of 26,096 shares. Despite this minor setback, Laurus Labs outperformed the Sensex, which gained 0.81% on the day. The stock’s pullback was modest and did not breach key support levels, maintaining its position above all major moving averages.
This consolidation phase may reflect short-term profit-taking after a strong rally, but the underlying fundamentals and technical indicators remain supportive of the stock’s current valuation and momentum.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2025-12-29 | Rs.1,082.00 | -0.25% | 37,140.23 | -0.41% |
| 2025-12-30 | Rs.1,090.80 | +0.81% | 37,135.83 | -0.01% |
| 2025-12-31 | Rs.1,108.20 | +1.60% | 37,443.41 | +0.83% |
| 2026-01-01 | Rs.1,110.10 | +0.17% | 37,497.10 | +0.14% |
| 2026-01-02 | Rs.1,107.70 | -0.22% | 37,799.57 | +0.81% |
Key Takeaways
Strong Price Momentum: Laurus Labs outperformed the Sensex by 0.77% over the week, gaining 2.12% versus the benchmark’s 1.35%. The stock’s ability to hit multiple 52-week and all-time highs highlights robust investor demand.
Exceptional Quarterly Earnings: The company’s September 2025 quarter results showed extraordinary profit growth, with net profit up 993.4% and PBT rising 1233.17%, underpinning the stock’s rally.
Technical Strength: Consistent trading above all major moving averages throughout the week signals sustained technical support and positive market sentiment.
Institutional Confidence: Significant institutional holdings at 37.63% provide a stable shareholder base and reflect confidence in the company’s fundamentals and growth prospects.
Valuation Considerations: While the stock trades at a premium valuation, it remains discounted relative to peers’ historical averages, with a low PEG ratio of 0.2 indicating earnings growth outpacing price appreciation.
Conclusion
Laurus Labs Ltd’s performance during the week ending 2 January 2026 was marked by steady gains, technical resilience, and strong fundamental support. The stock’s ability to set new 52-week and all-time highs amid a broadly positive market environment underscores its leadership within the Pharmaceuticals & Biotechnology sector. Exceptional quarterly earnings growth and robust institutional backing further reinforce the company’s market position. Although the stock experienced a minor pullback on the final trading day, its overall momentum and valuation metrics suggest a well-supported trajectory as it enters the new year.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Saving Now →
